128 related articles for article (PubMed ID: 7557889)
1. p53 proteins and aflatoxin b1: the good, the bad, and the ugly.
Liang TJ
Hepatology; 1995 Oct; 22(4 Pt 1):1330-2. PubMed ID: 7557889
[No Abstract] [Full Text] [Related]
2. p53 mutations in nonmalignant human liver: fingerprints of aflatoxins?
Ozturk M
Hepatology; 1995 Feb; 21(2):600-1. PubMed ID: 7843737
[No Abstract] [Full Text] [Related]
3. Epidemiology of human aflatoxin exposures and their relationship to liver cancer.
Groopman JD; Scholl P; Wang JS
Prog Clin Biol Res; 1996; 395():211-22. PubMed ID: 8895991
[No Abstract] [Full Text] [Related]
4. Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma.
Yakicier MC; Legoix P; Vaury C; Gressin L; Tubacher E; Capron F; Bayer J; Degott C; Balabaud C; Zucman-Rossi J
Oncogene; 2001 Aug; 20(37):5232-8. PubMed ID: 11526514
[TBL] [Abstract][Full Text] [Related]
5. Aflatoxin and p53 abnormality in duck hepatocellular carcinoma.
Imazeki F; Yokosuka O; Ohto M; Omata M
J Gastroenterol Hepatol; 1995; 10(6):646-9. PubMed ID: 8580407
[TBL] [Abstract][Full Text] [Related]
6. The chemistry and biology of aflatoxin B(1): from mutational spectrometry to carcinogenesis.
Smela ME; Currier SS; Bailey EA; Essigmann JM
Carcinogenesis; 2001 Apr; 22(4):535-45. PubMed ID: 11285186
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma p53 G > T transversions at codon 249: the fingerprint of aflatoxin exposure?
Lasky T; Magder L
Environ Health Perspect; 1997 Apr; 105(4):392-7. PubMed ID: 9189703
[TBL] [Abstract][Full Text] [Related]
8. Geographic variation of p53 mutational profile in nonmalignant human liver.
Aguilar F; Harris CC; Sun T; Hollstein M; Cerutti P
Science; 1994 May; 264(5163):1317-9. PubMed ID: 8191284
[TBL] [Abstract][Full Text] [Related]
9. Different frequencies of p53 codon-249 hot-spot mutations in hepatocellular carcinomas in Jiang-su province of China.
Shimizu Y; Zhu JJ; Han F; Ishikawa T; Oda H
Int J Cancer; 1999 Jul; 82(2):187-90. PubMed ID: 10389750
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relationship to aflatoxin B1-DNA adducts and p53 mutation in hepatocellular carcinoma.
Zhang YJ; Chen Y; Ahsan H; Lunn RM; Lee PH; Chen CJ; Santella RM
Int J Cancer; 2003 Feb; 103(4):440-4. PubMed ID: 12478658
[TBL] [Abstract][Full Text] [Related]
11. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ
Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059
[TBL] [Abstract][Full Text] [Related]
12. Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis.
Shen HM; Ong CN
Mutat Res; 1996 Oct; 366(1):23-44. PubMed ID: 8921985
[TBL] [Abstract][Full Text] [Related]
13. Absence of mutations in the p53 tumor suppressor gene in woodchuck hepatocellular carcinomas associated with hepadnavirus infection and intake of aflatoxin B1.
Rivkina M; Cote PJ; Robinson WS; Tennant BC; Marion PL
Carcinogenesis; 1996 Dec; 17(12):2689-94. PubMed ID: 9006107
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of aflatoxin, mutant P53 gene and sIL-2 receptor in liver cirrhosis and hepatocellular carcinoma.
El-Shanawani FM; Abdel-Hadi AA; Abu Zikri NB; Ismail A; El-Ansary M; El-Raai A
J Egypt Soc Parasitol; 2006 Apr; 36(1):221-39. PubMed ID: 16605112
[TBL] [Abstract][Full Text] [Related]
15. Aflatoxins as a cause of hepatocellular carcinoma.
Kew MC
J Gastrointestin Liver Dis; 2013 Sep; 22(3):305-10. PubMed ID: 24078988
[TBL] [Abstract][Full Text] [Related]
16. Aflatoxin and hepatocellular carcinoma: a useful paradigm for environmentally induced carcinogenesis.
Kolars JC
Hepatology; 1992 Sep; 16(3):848-51. PubMed ID: 1324219
[No Abstract] [Full Text] [Related]
17. Evidence that mutational activation of the ras genes may not be involved in aflatoxin B(1)-induced human hepatocarcinogenesis, based on sequence analysis of the ras and p53 genes.
Chao HK; Tsai TF; Lin CS; Su TS
Mol Carcinog; 1999 Oct; 26(2):69-73. PubMed ID: 10506750
[TBL] [Abstract][Full Text] [Related]
18. An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico.
Soini Y; Chia SC; Bennett WP; Groopman JD; Wang JS; DeBenedetti VM; Cawley H; Welsh JA; Hansen C; Bergasa NV; Jones EA; DiBisceglie AM; Trivers GE; Sandoval CA; Calderon IE; Munoz Espinosa LE; Harris CC
Carcinogenesis; 1996 May; 17(5):1007-12. PubMed ID: 8640905
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxin B1.
Park US; Su JJ; Ban KC; Qin L; Lee EH; Lee YI
Gene; 2000 Jun; 251(1):73-80. PubMed ID: 10863098
[TBL] [Abstract][Full Text] [Related]
20. Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene.
Cerutti P; Hussain P; Pourzand C; Aguilar F
Cancer Res; 1994 Apr; 54(7 Suppl):1934s-1938s. PubMed ID: 7907948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
